최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Antiviral research, v.137, 2017년, pp.82 - 92
Liu, W.J. , Zhao, M. , Liu, K. , Xu, K. , Wong, G. , Tan, W. , Gao, G.F.
Over 12 years have elapsed since severe acute respiratory syndrome (SARS) triggered the first global alert for coronavirus infections. Virus transmission in humans was quickly halted by public health measures and human infections of SARS coronavirus (SARS-CoV) have not been observed since. However, ...
Agnihothram S. Gopal R. Yount B.L. Jr. Donaldson E.F. Menachery V.D. Graham R.L. Scobey T.D. Gralinski L.E. Denison M.R. Zambon M. Baric R.S. Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses J.?Infect. Dis. 209 2014 995 1006 24253287
Akbari O. Panjwani N. Garcia S. Tascon R. Lowrie D. Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity J.?Exp. Med. 189 1999 169 178 9874573
Al-Abdallat M.M. Payne D.C. Alqasrawi S. Rha B. Tohme R.A. Abedi G.R. Al Nsour M. Iblan I. Jarour N. Farag N.H. Haddadin A. Al-Sanouri T. Tamin A. Harcourt J.L. Kuhar D.T. Swerdlow D.L. Erdman D.D. Pallansch M.A. Haynes L.M. Gerber S.I. Jordan M.-C.I.T. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description Clin. Infect. Dis. 59 2014 1225 1233 24829216
Alshukairi A.N. Khalid I. Ahmed W.A. Dada A.M. Bayumi D.T. Malic L.S. Althawadi S. Ignacio K. Alsalmi H.S. Al-Abdely H.M. Wali G.Y. Qushmaq I.A. Alraddadi B.M. Perlman S. Antibody response and disease severity in healthcare worker MERS survivors Emerg. Infect. Dis. 22 6 2016
Arabi Y.M. Hajeer A.H. Luke T. Raviprakash K. Balkhy H. Johani S. Al-Dawood A. Al-Qahtani S. Al-Omari A. Al-Hameed F. Hayden F.G. Fowler R. Bouchama A. Shindo N. Al-Khairy K. Carson G. Taha Y. Sadat M. Alahmadi M. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia Emerg. Infect. Dis. 22 2016 1554 1561 27532807
Blicher T. Kastrup J.S. Buus S. Gajhede M. High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide Acta Crystallogr. D. Biol. Crystallogr. 61 2005 1031 1040 16041067
Cameron M.J. Ran L. Xu L. Danesh A. Bermejo-Martin J.F. Cameron C.M. Muller M.P. Gold W.L. Richardson S.E. Poutanen S.M. Willey B.M. DeVries M.E. Fang Y. Seneviratne C. Bosinger S.E. Persad D. Wilkinson P. Greller L.D. Somogyi R. Humar A. Keshavjee S. Louie M. Loeb M.B. Brunton J. McGeer A.J. Canadian S.R.N. Kelvin D.J. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome J.?Virol. 81 2007 8692 8706 17537853
Chan K.H. Chan J.F. Tse H. Chen H. Lau C.C. Cai J.P. Tsang A.K. Xiao X. To K.K. Lau S.K. Woo P.C. Zheng B.J. Wang M. Yuen K.Y. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests J.?Infect. Dis. 67 2013 130 140
Channappanavar R. Fehr A.R. Vijay R. Mack M. Zhao J. Meyerholz D.K. Perlman S. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Cell Host Microbe 19 2016 181 193 26867177
Channappanavar R. Fett C. Zhao J. Meyerholz D.K. Perlman S. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection J.?Virol. 88 2014 11034 11044 25056892
Chen H. Hou J. Jiang X. Ma S. Meng M. Wang B. Zhang M. Zhang M. Tang X. Zhang F. Wan T. Li N. Yu Y. Hu H. Yang R. He W. Wang X. Cao X. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals J.?Immunol. 175 2005 591 598 15972696
Chen J. Lau Y.F. Lamirande E.W. Paddock C.D. Bartlett J.H. Zaki S.R. Subbarao K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection J.?Virol. 84 2010 1289 1301 19906920
Chen X. Yang X. Zheng Y. Yang Y. Xing Y. Chen Z. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex Protein Cell 5 2014 369 381 24622840
Chen Y.Z. Liu G. Senju S. Wang Q. Irie A. Haruta M. Matsui M. Yasui F. Kohara M. Nishimura Y. Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant Int. J. Immunopathol. Pharmacol. 23 2010 165 177 20378004
Cheung Y.K. Cheng S.C. Sin F.W. Chan K.T. Xie Y. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope Vaccine 25 2007 6070 6077 17629360
Chu H. Zhou J. Wong B.H. Li C. Chan J.F. Cheng Z.S. Yang D. Wang D. Lee A.C. Li C. Yeung M.L. Cai J.P. Chan I.H. Ho W.K. To K.K. Zheng B.J. Yao Y. Qin C. Yuen K.Y. Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways J.?Infect. Dis. 213 2016 904 914 26203058
Corman V.M. Albarrak A.M. Omrani A.S. Albarrak M.M. Farah M.E. Almasri M. Muth D. Sieberg A. Meyer B. Assiri A.M. Binger T. Steinhagen K. Lattwein E. Al-Tawfiq J. Muller M.A. Drosten C. Memish Z.A. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection Clin. Infect. Dis. 62 2016 477 483 26565003
Corman V.M. Ithete N.L. Richards L.R. Schoeman M.C. Preiser W. Drosten C. Drexler J.F. Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat J.?Virol. 88 2014 11297 11303 25031349
Corti D. Zhao J. Pedotti M. Simonelli L. Agnihothram S. Fett C. Fernandez-Rodriguez B. Foglierini M. Agatic G. Vanzetta F. Gopal R. Langrish C.J. Barrett N.A. Sallusto F. Baric R.S. Varani L. Zambon M. Perlman S. Lanzavecchia A. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus Proc. Natl. Acad. Sci. U. S. A. 112 2015 10473 10478 26216974
Da Guan W. Mok C.K. Chen Z.L. Feng L.Q. Li Z.T. Huang J.C. Ke C.W. Deng X. Ling Y. Wu S.G. Niu X.F. Perera R.A. Da Xu Y. Zhao J. Zhang L.Q. Li Y.M. Chen R.C. Peiris M. Chen L. Zhong N.S. Characteristics of traveler with Middle East respiratory syndrome, China, 2015 Emerg. Infect. Dis. 21 2015 2278 2280 26583433
Doytchinova I. Flower D. The HLA-A2-supermotif: a QSAR definition Organ. Biomol. Chem. 1 2003 2648 2654
Du L. He Y. Zhou Y. Liu S. Zheng B.J. Jiang S. The spike protein of SARS-CoV?a target for vaccine and therapeutic development Nat. Rev. Microbiol. 7 2009 226 236 19198616
Du L. Ma C. Jiang S. Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC J.?Infect. 67 2013 348 350 23685240
Du L. Tai W. Zhou Y. Jiang S. Vaccines for the prevention against the threat of MERS-CoV Expert Rev. Vac. 15 2016 1123 1134
Du L. Zhao G. Chan C.C. Li L. He Y. Zhou Y. Zheng B.J. Jiang S. A?219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity Viral Immunol. 23 2010 211 219 20374001
Du L. Zhao G. Li L. He Y. Zhou Y. Zheng B.J. Jiang S. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells Biochem. Biophys. Res. Commun. 384 2009 486 490 19422787
Du L. Zhao G. Lin Y. Sui H. Chan C. Ma S. He Y. Jiang S. Wu C. Yuen K.Y. Jin D.Y. Zhou Y. Zheng B.J. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection J.?Immunol. 180 2008 948 956 18178835
Fan Y.Y. Huang Z.T. Li L. Wu M.H. Yu T. Koup R.A. Bailer R.T. Wu C.Y. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection Arch. Virol. 154 2009 1093 1099 19526193
Faure E. Poissy J. Goffard A. Fournier C. Kipnis E. Titecat M. Bortolotti P. Martinez L. Dubucquoi S. Dessein R. Gosset P. Mathieu D. Guery B. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PloS One 9 2014 e88716 24551142
Feng Y. Gao G.F. Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus Comp. Immunol. Microbiol. Infect. Dis. 30 2007 309 327 17640731
Frieman M.B. Chen J. Morrison T.E. Whitmore A. Funkhouser W. Ward J.M. Lamirande E.W. Roberts A. Heise M. Subbarao K. Baric R.S. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism PLoS Pathog. 6 2010 e1000849 20386712
Gu J. Gong E. Zhang B. Zheng J. Gao Z. Zhong Y. Zou W. Zhan J. Wang S. Xie Z. Zhuang H. Wu B. Zhong H. Shao H. Fang W. Gao D. Pei F. Li X. He Z. Xu D. Shi X. Anderson V.M. Leong A.S. Multiple organ infection and the pathogenesis of SARS J.?Exp. Med. 202 2005 415 424 16043521
He Y. Zhou Y. Siddiqui P. Niu J. Jiang S. Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus J.?Clin. Microbiol. 43 2005 3718 3726 16081901
Hijawi B. Abdallat M. Sayaydeh A. Alqasrawi S. Haddadin A. Jaarour N. Alsheikh S. Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation East Mediterr Health J 19 Suppl.?1 2013 S12 S18 23888790
Hilgenfeld R. Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses Antivir. Res. 100 2013 286 295 24012996
Hsueh P.R. Huang L.M. Chen P.J. Kao C.L. Yang P.C. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus Clin. Microbiol. Infect. 10 2004 1062 1066 15606632
Huang J. Cao Y. Du J. Bu X. Ma R. Wu C. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses Vaccine 25 2007 6981 6991 17709158
Huang M. Zhang W. Guo J. Wei X. Phiwpan K. Zhang J. Zhou X. Improved transgenic mouse model for studying HLA class I antigen presentation Sci. Rep. 6 2016 33612 27634283
Jauregui A.R. Savalia D. Lowry V.K. Farrell C.M. Wathelet M.G. Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling PloS One 8 2013 e62416 23658627
Julien J.-P. Lee P.S. Wilson I.A. Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA Immunol. Rev. 250 2012 180 198 23046130
Kapoor M. Pringle K. Kumar A. Dearth S. Liu L. Lovchik J. Perez O. Pontones P. Richards S. Yeadon-Fagbohun J. Breakwell L. Chea N. Cohen N.J. Schneider E. Erdman D. Haynes L. Pallansch M. Tao Y. Tong S. Gerber S. Swerdlow D. Feikin D.R. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States Clin. Infect. Dis. 59 2014 1511 1518 25100864
Kohyama S. Ohno S. Suda T. Taneichi M. Yokoyama S. Mori M. Kobayashi A. Hayashi H. Uchida T. Matsui M. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a Antivir. Res. 84 2009 168 177 19748524
Kopecky-Bromberg S.A. Martinez-Sobrido L. Frieman M. Baric R.A. Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists J.?Virol. 81 2007 548 557 17108024
Ksiazek T.G. Erdman D. Goldsmith C.S. Zaki S.R. Peret T. Emery S. Tong S. Urbani C. Comer J.A. Lim W. Rollin P.E. Dowell S.F. Ling A.E. Humphrey C.D. Shieh W.J. Guarner J. Paddock C.D. Rota P. Fields B. DeRisi J. Yang J.Y. Cox N. Hughes J.M. LeDuc J.W. Bellini W.J. Anderson L.J. Group S.W. A?novel coronavirus associated with severe acute respiratory syndrome New Engl. J. Med. 348 2003 1953 1966 12690092
Kuba K. Imai Y. Rao S. Gao H. Guo F. Guan B. Huan Y. Yang P. Zhang Y. Deng W. Bao L. Zhang B. Liu G. Wang Z. Chappell M. Liu Y. Zheng D. Leibbrandt A. Wada T. Slutsky A.S. Liu D. Qin C. Jiang C. Penninger J.M. A?crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Nat. Med. 11 2005 875 879 16007097
Lan J. Deng Y. Chen H. Lu G. Wang W. Guo X. Lu Z. Gao G.F. Tan W. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen PloS One 9 2014 e112602 25405618
Lau S.K. Li K.S. Tsang A.K. Lam C.S. Ahmed S. Chen H. Chan K.H. Woo P.C. Yuen K.Y. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus J.?Virol. 87 2013 8638 8650 23720729
Le Prevost C. Levy-Leblond E. Virelizier J.L. Dupuy J.M. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms J.?Immunol. 114 1975 221 225 163277
Leung D.T. Tam F.C. Ma C.H. Chan P.K. Cheung J.L. Niu H. Tam J.S. Lim P.L. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid J.?Infect. Dis. 190 2004 379 386 15216476
Li C.K. Wu H. Yan H. Ma S. Wang L. Zhang M. Tang X. Temperton N.J. Weiss R.A. Brenchley J.M. Douek D.C. Mongkolsapaya J. Tran B.H. Lin C.L. Screaton G.R. Hou J.L. McMichael A.J. Xu X.N. T?cell responses to whole SARS coronavirus in humans J.?Immunol. 181 2008 5490 5500 18832706
Li F. Li W. Farzan M. Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor Science 309 2005 1864 1868 16166518
Li H. Wang Y. Han Z. Wang Y. Liang S. Jiang L. Hu Y. Kong X. Liu S. Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens Antivir. Res. 130 2016 19 26 26946113
Li W. Shi Z. Yu M. Ren W. Smith C. Epstein J.H. Wang H. Crameri G. Hu Z. Zhang H. Zhang J. McEachern J. Field H. Daszak P. Eaton B.T. Zhang S. Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses Science 310 2005 676 679 16195424
Li Y. Wan Y. Liu P. Zhao J. Lu G. Qi J. Wang Q. Lu X. Wu Y. Liu W. Zhang B. Yuen K.Y. Perlman S. Gao G.F. Yan J. A?humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein Cell Res. 25 2015 1237 1249 26391698
Lin Y. Shen X. Yang R.F. Li Y.X. Ji Y.Y. He Y.Y. Shi M.D. Lu W. Shi T.L. Wang J. Wang H.X. Jiang H.L. Shen J.H. Xie Y.H. Wang Y. Pei G. Shen B.F. Wu J.R. Sun B. Identification of an epitope of SARS-coronavirus nucleocapsid protein Cell Res. 13 2003 141 145 12862314
Liu J. Qi J. Gao F. Yan J. Gao G.F. Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes Sci. Tech. Rev. China 29 2011 8
Liu J. Sun Y. Qi J. Chu F. Wu H. Gao F. Li T. Yan J. Gao G.F. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes J.?Infect. Dis. 202 2010 1171 1180 20831383
Liu J. Wu P. Gao F. Qi J. Kawana-Tachikawa A. Xie J. Vavricka C.J. Iwamoto A. Li T. Gao G.F. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein J.?Virol. 84 2010 11849 11857 20844028
Liu J. Zhang S. Tan S. Zheng B. Gao G.F. Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development Exp. Biol. Med. 236 2011 253 267
Liu P. Liu D. Yang X. Gao J. Chen Y. Xiao X. Liu F. Zou J. Wu J. Ma J. Zhao F. Zhou X. Gao G.F. Zhu B. Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains Protein Cell 5 2014 603 615 24866699
Liu W. Fontanet A. Zhang P.H. Zhan L. Xin Z.T. Baril L. Tang F. Lv H. Cao W.C. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome J.?Infect. Dis. 193 2006 792 795 16479513
Liu W.J. Lan J. Liu K. Deng Y. Yao Y. Wu S. Chen H. Bao L. Zhang H. Zhao M. Wang Q. Han L. Chai Y. Qi J. Zhao J. Meng S. Qin C. Gao G.F. Tan W. Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC J. Immunol. 2016 (in press)
Liu Y.V. Massare M.J. Barnard D.L. Kort T. Nathan M. Wang L. Smith G. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV Vaccine 29 2011 6606 6613 21762752
Lokugamage K.G. Yoshikawa-Iwata N. Ito N. Watts D.M. Wyde P.R. Wang N. Newman P. Kent Tseng C.T. Peters C.J. Makino S. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV Vaccine 26 2008 797 808 18191004
Lu G. Hu Y. Wang Q. Qi J. Gao F. Li Y. Zhang Y. Zhang W. Yuan Y. Bao J. Zhang B. Shi Y. Yan J. Gao G.F. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 Nature 500 2013 227 231 23831647
Lu G. Wang Q. Gao G.F. Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond Trends Microbiol. 23 2015 468 478 26206723
Lv Y. Ruan Z. Wang L. Ni B. Wu Y. Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV BMC Immunol. 10 2009 61 19958537
MacNamara K.C. Bender S.J. Chua M.M. Watson R. Weiss S.R. Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent J.?Virol. 82 2008 6150 6160 18417581
Martin J.E. Louder M.K. Holman L.A. Gordon I.J. Enama M.E. Larkin B.D. Andrews C.A. Vogel L. Koup R.A. Roederer M. Bailer R.T. Gomez P.L. Nason M. Mascola J.R. Nabel G.J. Graham B.S. Team V.R.C.S. A?SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial Vaccine 26 2008 6338 6343 18824060
Menachery V.D. Yount B.L. Jr. Josset L. Gralinski L.E. Scobey T. Agnihothram S. Katze M.G. Baric R.S. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity J.?Virol. 88 2014 4251 4264 24478444
Meyer B. Drosten C. Muller M.A. Serological assays for emerging coronaviruses: challenges and pitfalls Virus Res. 194 2014 175 183 24670324
Min C.K. Cheon S. Ha N.Y. Sohn K.M. Kim Y. Aigerim A. Shin H.M. Choi J.Y. Inn K.S. Kim J.H. Moon J.Y. Choi M.S. Cho N.H. Kim Y.S. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity Sci. Rep. 6 2016 25359 27146253
Morimoto C. Schlossman S.F. The structure and function of CD26 in the T-cell immune response Immunol. Rev. 161 1998 55 70 9553764
Ng O.W. Chia A. Tan A.T. Jadi R.S. Leong H.N. Bertoletti A. Tan Y.J. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection Vaccine 34 2016 2008 2014 26954467
Niemeyer D. Zillinger T. Muth D. Zielecki F. Horvath G. Suliman T. Barchet W. Weber F. Drosten C. Muller M.A. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist J.?Virol. 87 2013 12489 12495 24027320
Oh H.L. Chia A. Chang C.X. Leong H.N. Ling K.L. Grotenbreg G.M. Gehring A.J. Tan Y.J. Bertoletti A. Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope J.?Virol. 85 2011 10464 10471 21813600
Ohno S. Kohyama S. Taneichi M. Moriya O. Hayashi H. Oda H. Mori M. Kobayashi A. Akatsuka T. Uchida T. Matsui M. Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice Vaccine 27 2009 3912 3920 19490987
Park W.B. Perera R.A. Choe P.G. Lau E.H. Choi S.J. Chun J.Y. Oh H.S. Song K.H. Bang J.H. Kim E.S. Kim H.B. Park S.W. Kim N.J. Man Poon L.L. Peiris M. Oh M.D. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea Emerg. Infect. Dis. 21 2015 2186 2189 26583829
Peng H. Yang L.T. Wang L.Y. Li J. Huang J. Lu Z.Q. Koup R.A. Bailer R.T. Wu C.Y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients Virology 351 2006 466 475 16690096
Poh W.P. Narasaraju T. Pereira N.A. Zhong F. Phoon M.C. Macary P.A. Wong S.H. Lu J. Koh D.R. Chow V.T. Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif J. Med. Virol. 81 2009 1131 1139 19475608
Raj V.S. Mou H. Smits S.L. Dekkers D.H. Muller M.A. Dijkman R. Muth D. Demmers J.A. Zaki A. Fouchier R.A. Thiel V. Drosten C. Rottier P.J. Osterhaus A.D. Bosch B.J. Haagmans B.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature 495 2013 251 254 23486063
Reusken C. Mou H. Godeke G.J. van der Hoek L. Meyer B. Muller M.A. Haagmans B. de Sousa R. Schuurman N. Dittmer U. Rottier P. Osterhaus A. Drosten C. Bosch B.J. Koopmans M. Specific serology for emerging human coronaviruses by protein microarray Euro Surveil 18 2013 20441
Reusken C.B. Messadi L. Feyisa A. Ularamu H. Godeke G.J. Danmarwa A. Dawo F. Jemli M. Melaku S. Shamaki D. Woma Y. Wungak Y. Gebremedhin E.Z. Zutt I. Bosch B.J. Haagmans B.L. Koopmans M.P. Geographic distribution of MERS coronavirus among dromedary camels, Africa Emerg. Infect. Dis. 20 2014 1370 1374 25062254
Rivino L. Tan A.T. Chia A. Kumaran E.A. Grotenbreg G.M. MacAry P.A. Bertoletti A. Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity J. Immunol. 191 2013 4010 4019 24058176
Roder G. Kristensen O. Kastrup J.S. Buus S. Gajhede M. Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501 Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 64 2008 459 462
Rota P.A. Oberste M.S. Monroe S.S. Nix W.A. Campagnoli R. Icenogle J.P. Penaranda S. Bankamp B. Maher K. Chen M.H. Tong S. Tamin A. Lowe L. Frace M. DeRisi J.L. Chen Q. Wang D. Erdman D.D. Peret T.C. Burns C. Ksiazek T.G. Rollin P.E. Sanchez A. Liffick S. Holloway B. Limor J. McCaustland K. Olsen-Rasmussen M. Fouchier R. Gunther S. Osterhaus A.D. Drosten C. Pallansch M.A. Anderson L.J. Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 2003 1394 1399 12730500
Sharpe H.J. Stevens T.J. Munro S. A?comprehensive comparison of transmembrane domains reveals organelle-specific properties Cell 142 2010 158 169 20603021
Stohlman S.A. Bergmann C.C. van der Veen R.C. Hinton D.R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system J.?Virol. 69 1995 684 694 7815531
Su S. Wong G. Liu Y. Gao G.F. Li S. Bi Y. MERS in South Korea and China: a potential outbreak threat? Lancet 385 2015 2349 2350 26088634
Su S. Wong G. Shi W. Liu J. Lai A.C. Zhou J. Liu W. Bi Y. Gao G.F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses Trend Microbiol. 24 2016 490 502
Sun L. Zhang Y. Zhao B. Deng M. Liu J. Li X. Hou J. Gui M. Zhang S. Li X. Gao G.F. Meng S. A?new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes Protein Cell 5 2014 317 327 24659387
Takano T. Tomizawa K. Morioka H. Doki T. Hohdatsu T. Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats Antivir. Ther. 19 2014 645 650 24458025
Tang F. Quan Y. Xin Z.T. Wrammert J. Ma M.J. Lv H. Wang T.B. Yang H. Richardus J.H. Liu W. Cao W.C. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study J.?Immunol. 186 2011 7264 7268 21576510
Tang X.C. Agnihothram S.S. Jiao Y. Stanhope J. Graham R.L. Peterson E.C. Avnir Y. Tallarico A.S. Sheehan J. Zhu Q. Baric R.S. Marasco W.A. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution Proc. Natl. Acad. Sci. U. S. A. 111 2014 E2018 E2026 24778221
To K.K. Hung I.F. Chan J.F. Yuen K.Y. From SARS coronavirus to novel animal and human coronaviruses J.?Thorac. Dis. 5 2013 S103 S108 23977429
Trujillo J.A. Gras S. Twist K.A. Croft N.P. Channappanavar R. Rossjohn J. Purcell A.W. Perlman S. Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes J.?Immunol. 192 2014 5245 5256 24795457
Tsao Y.P. Lin J.Y. Jan J.T. Leng C.H. Chu C.C. Yang Y.C. Chen S.L. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins Biochem. Biophys. Res. Commun. 344 2006 63 71 16630549
Tseng C.T. Sbrana E. Iwata-Yoshikawa N. Newman P.C. Garron T. Atmar R.L. Peters C.J. Couch R.B. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus PloS One 7 2012 e35421 22536382
Vijay R. Perlman S. Middle East respiratory syndrome and severe acute respiratory syndrome Curr. Opin. Virol. 16 2016 70 76 26855039
Volz A. Kupke A. Song F. Jany S. Fux R. Shams-Eldin H. Schmidt J. Becker C. Eickmann M. Becker S. Sutter G. Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein J.?Virol. 89 2015 8651 8656 26018172
Wang B.M. Chen H.B. Jiang X.D. Zhang M.H. Wan T. Li N. Zhou X.Y. Wu Y.F. Yang F. Yu Y.Z. Wang X.N. Yang R.F. Cao X.T. Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein Blood 104 2004 200 206 15016646
Wang Q. Qi J. Yuan Y. Xuan Y. Han P. Wan Y. Ji W. Li Y. Wu Y. Wang J. Iwamoto A. Woo P.C. Yuen K.Y. Yan J. Lu G. Gao G.F. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26 Cell Host Microbe 16 2014 328 337 25211075
Wang Q. Wong G. Lu G. Yan J. Gao G.F. MERS-CoV spike protein: targets for vaccines and therapeutics Antivir. Res. 133 2016 165 177 27468951
Wang W.L. Wang H.J. Deng Y. Song T. Lan J.M. Wu G.Z. Ke C.W. Tan W.J. Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015 Biomed. Environ. Sci. 29 2016 219 223 27109133
Wang Y. Liu D. Shi W. Lu R. Wang W. Zhao Y. Deng Y. Zhou W. Ren H. Wu J. Wang Y. Wu G. Gao G.F. Tan W. Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis mBio 6 2015 e01280?01215
Wang Y.D. Sin W.Y. Xu G.B. Yang H.H. Wong T.Y. Pang X.W. He X.Y. Zhang H.G. Ng J.N. Cheng C.S. Yu J. Meng L. Yang R.F. Lai S.T. Guo Z.H. Xie Y. Chen W.F. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS J. Virol. 78 2004 5612 5618 15140958
Wong G. Liu W. Liu Y. Zhou B. Bi Y. Gao G.F. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease Cell Host Microbe 18 2015 398 401 26468744
Woo P.C. Lau S.K. Wong B.H. Tsoi H.W. Fung A.M. Chan K.H. Tam V.K. Peiris J.S. Yuen K.Y. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia J.?Clin. Microbiol. 42 2004 2306 2309 15131220
Yang K. Sun K. Srinivasan K.N. Salmon J. Marques E.T. Xu J. August J.T. Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein Gene Ther. 16 2009 1353 1362 19727132
Yang L. Peng H. Zhu Z. Li G. Huang Z. Zhao Z. Koup R.A. Bailer R.T. Wu C. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen J.?Gen. Virol. 88 2007 2740 2748 17872527
Yang L.T. Peng H. Zhu Z.L. Li G. Huang Z.T. Zhao Z.X. Koup R.A. Bailer R.T. Wu C.Y. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients Clin. Immunol. 120 2006 171 178 16781892
Yang Y. Ye F. Zhu N. Wang W. Deng Y. Zhao Z. Tan W. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets Sci. Rep. 5 2015 17554 26631542
Zaki A.M. van Boheemen S. Bestebroer T.M. Osterhaus A.D. Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia New Engl. J. Med. 367 2012 1814 1820 23075143
Zhang N. Jiang S. Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines Expert Rev. Vac. 13 2014 761 774
Zhang S. Bakshi R.K. Suneetha P.V. Fytili P. Antunes D.A. Vieira G.F. Jacobs R. Klade C.S. Manns M.P. Kraft A.R. Wedemeyer H. Schlaphoff V. Cornberg M. Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses J.?Virol. 89 2015 8304 8317 26041301
Zhao J. Huang Q. Wang W. Zhang Y. Lv P. Gao X.M. Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus J.?Virol. 81 2007 6079 6088 17392374
Zhao J. Perera R.A. Kayali G. Meyerholz D. Perlman S. Peiris M. Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection J.?Virol. 89 2015 6117 6120 25787284
Zhao J. Zhao J. Mangalam A.K. Channappanavar R. Fett C. Meyerholz D.K. Agnihothram S. Baric R.S. David C.S. Perlman S. Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses Immunity 44 2016 1379 1391 27287409
Zhao J. Zhao J. Perlman S. T?cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice J.?Virol. 84 2010 9318 9325 20610717
Zhao K. Wang H. Wu C. The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848 Vaccine 29 2011 6670 6678 21745520
Zhao K. Yang B. Xu Y. Wu C. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein Vaccine 28 2010 6666 6674 20709007
Zhi Y. Kobinger G.P. Jordan H. Suchma K. Weiss S.R. Shen H. Schumer G. Gao G. Boyer J.L. Crystal R.G. Wilson J.M. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein Virology 335 2005 34 45 15823604
Zhou J. Chu H. Li C. Wong B.H. Cheng Z.S. Poon V.K. Sun T. Lau C.C. Wong K.K. Chan J.Y. Chan J.F. To K.K. Chan K.H. Zheng B.J. Yuen K.Y. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis J.?Infect. Dis. 209 2014 1331 1342 24065148
Zhou M. Xu D. Li X. Li H. Shan M. Tang J. Wang M. Wang F.S. Zhu X. Tao H. He W. Tien P. Gao G.F. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes J.?Immunol. 177 2006 2138 2145 16887973
Zhou T. Georgiev I. Wu X. Yang Z.Y. Dai K. Finzi A. Kwon Y.D. Scheid J.F. Shi W. Xu L. Yang Y. Zhu J. Nussenzweig M.C. Sodroski J. Shapiro L. Nabel G.J. Mascola J.R. Kwong P.D. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 Science 329 2010 811 817 20616231
Zust R. Cervantes-Barragan L. Kuri T. Blakqori G. Weber F. Ludewig B. Thiel V. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines PLoS Pathog. 3 2007 e109 17696607
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.